The wound debridement market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029. Increasing incidence of wounds due to diabetes, venous leg ulcers and surgeries are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and increasing wound infections. According to the research, the annual incidence of diabetic foot ulcer worldwide is between 9.1 to 26.1 million.
The market is segmented based on product into gel and ointment, medical debridement pads, medical gauzes, enzymatic debridement products and, others, out of which, the gels segment is anticipated to grab the largest share by the end of 2021 as gels are having property to avoid enzymatic activity and drug interaction with food and drinks. In addition, no inflammation, less bleeding, removal of necrotic tissue safely and without infection are some factors that are contributing to the growth of this segment.CLICK TO DOWNLOAD SAMPLE REPORT
On the basis of application, diabetic foot ulcers are observed as the fastest growing segment due to increasing prevalence of diabetes. Furthermore, pressure ulcers are anticipated to hold the largest share in the market in owing to increasing incidence of bedsores. In addition, skin of aged people is highly sensitive and is more prone towards developing bedsores, thereby bolstering the growth of the segment.
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. Asia Pacific region is poised to witness lucrative growth during the forecast period due to booming economies, reforms to improve healthcare infrastructure facilities to provide growth of the regional market. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, the growth of the region can be attributed to the presence of developed medical infrastructure and increasing patient awareness coupled with rising disposable income and soaring need for quality medical products and services. As per the analysis of American Diabetes Association, diabetes affects 30 million people in the US and more than 415 million people worldwide.
The wound debridement market is further classified on the basis of region as follows:
Our in-depth analysis of the global wound debridement market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Growing incidence of pressure ulcers, diabetic foot and surgical procedures and rise in the incidence of wound infections are the key factors driving market growth.
The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.
High cost of treatment are estimated to hamper market growth.
The market in Asia Pacific region will provide ample growth opportunities owing to the improving healthcare infrastructure and facilities.
The major players dominating the wound debridement market are Smith & Nephew, B. Braun Melsungen AG, Zimmer Biomet, Misonix, MediWound among others.
The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product, wound type and region.
With respect to application, pressure ulcers are anticipated to hold the largest share in the market in owing to increasing incidence of bedsores
Select License Type
Direct access to analyst to help you understand the market in a better way to handle your critical question
Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved
Get 10% free customization